| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |